Les troubles du collagène peuvent-ils entraîner des problèmes cardiovasculaires ?
Oui, certaines anomalies du collagène peuvent augmenter le risque de maladies cardiovasculaires.
Problèmes cardiovasculairesAnomalies du collagèneSanté cardiovasculaire
#3
Comment les complications affectent-elles la qualité de vie ?
Les complications peuvent réduire la mobilité et causer des douleurs, affectant la qualité de vie.
Qualité de vieMobilitéDouleurs
#4
Les complications sont-elles réversibles ?
Certaines complications peuvent être gérées, mais d'autres peuvent être permanentes.
ComplicationsGestionPermanence
#5
Les complications peuvent-elles survenir à tout âge ?
Oui, les complications peuvent survenir à tout âge, mais elles sont plus fréquentes chez les personnes âgées.
ÂgeComplicationsPersonnes âgées
Facteurs de risque
5
#1
Quels sont les facteurs de risque pour les troubles du collagène de type V ?
Les facteurs incluent des antécédents familiaux, des maladies auto-immunes et des blessures répétées.
Facteurs de risqueAntécédents familiauxMaladies auto-immunes
#2
L'âge est-il un facteur de risque pour le collagène de type V ?
Oui, le vieillissement peut augmenter le risque de troubles liés au collagène.
ÂgeVieillissementCollagène
#3
Le sexe influence-t-il le risque de troubles du collagène ?
Oui, certaines conditions touchent plus fréquemment les femmes que les hommes.
SexeConditions médicalesCollagène
#4
Les habitudes de vie affectent-elles le risque de troubles du collagène ?
Oui, des habitudes comme le tabagisme et une mauvaise alimentation augmentent le risque.
Habitudes de vieTabagismeAlimentation
#5
Les maladies génétiques sont-elles un facteur de risque ?
Oui, certaines maladies génétiques peuvent prédisposer aux troubles du collagène de type V.
Maladies génétiquesPrédispositionCollagène
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Collagène de type V : Questions médicales les plus fréquentes",
"headline": "Collagène de type V : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Collagène de type V : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-09",
"dateModified": "2025-05-04",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Collagène de type V"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Collagènes fibrillaires",
"url": "https://questionsmedicales.fr/mesh/D024022",
"about": {
"@type": "MedicalCondition",
"name": "Collagènes fibrillaires",
"code": {
"@type": "MedicalCode",
"code": "D024022",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.860.300.250.300"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Collagène de type V",
"alternateName": "Collagen Type V",
"code": {
"@type": "MedicalCode",
"code": "D024062",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Vera Luiza Capelozzi",
"url": "https://questionsmedicales.fr/author/Vera%20Luiza%20Capelozzi",
"affiliation": {
"@type": "Organization",
"name": "Department of Pathology, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil."
}
},
{
"@type": "Person",
"name": "Ana Paula Pereira Velosa",
"url": "https://questionsmedicales.fr/author/Ana%20Paula%20Pereira%20Velosa",
"affiliation": {
"@type": "Organization",
"name": "Division of Rheumatology, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil."
}
},
{
"@type": "Person",
"name": "Solange Carrasco",
"url": "https://questionsmedicales.fr/author/Solange%20Carrasco",
"affiliation": {
"@type": "Organization",
"name": "Division of Rheumatology, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil."
}
},
{
"@type": "Person",
"name": "David E Birk",
"url": "https://questionsmedicales.fr/author/David%20E%20Birk",
"affiliation": {
"@type": "Organization",
"name": "University of South Florida College of Medicine, Tampa, FL 33612, USA."
}
},
{
"@type": "Person",
"name": "Lin Han",
"url": "https://questionsmedicales.fr/author/Lin%20Han",
"affiliation": {
"@type": "Organization",
"name": "School of Biomedical Engineering, Science and Health Systems, Drexel University, Philadelphia, PA 19104, United States. Electronic address: lh535@drexel.edu."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Cataracts.",
"datePublished": "2022-12-21",
"url": "https://questionsmedicales.fr/article/36565712",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/S0140-6736(22)01839-6"
}
},
{
"@type": "ScholarlyArticle",
"name": "Ontario Cataract Quality Outcome Initiative: appropriateness and prioritization of cataract surgery.",
"datePublished": "2022-07-02",
"url": "https://questionsmedicales.fr/article/35792177",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jcjo.2022.05.010"
}
},
{
"@type": "ScholarlyArticle",
"name": "Outcomes of cataract surgery in children who present with cataract at uveitis diagnosis.",
"datePublished": "2023-05-13",
"url": "https://questionsmedicales.fr/article/37187405",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jaapos.2023.02.010"
}
},
{
"@type": "ScholarlyArticle",
"name": "Laser-assisted cataract surgery versus standard ultrasound phacoemulsification cataract surgery.",
"datePublished": "2023-06-23",
"url": "https://questionsmedicales.fr/article/37369549",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/14651858.CD010735.pub3"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cataract surgery in patients with uveitis: Data from the Swedish National Cataract Register.",
"datePublished": "2022-12-20",
"url": "https://questionsmedicales.fr/article/36537142",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/aos.15308"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Scléroprotéines",
"item": "https://questionsmedicales.fr/mesh/D012596"
},
{
"@type": "ListItem",
"position": 5,
"name": "Protéines de la matrice extracellulaire",
"item": "https://questionsmedicales.fr/mesh/D016326"
},
{
"@type": "ListItem",
"position": 6,
"name": "Collagène",
"item": "https://questionsmedicales.fr/mesh/D003094"
},
{
"@type": "ListItem",
"position": 7,
"name": "Collagènes fibrillaires",
"item": "https://questionsmedicales.fr/mesh/D024022"
},
{
"@type": "ListItem",
"position": 8,
"name": "Collagène de type V",
"item": "https://questionsmedicales.fr/mesh/D024062"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Collagène de type V - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Collagène de type V",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-08",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Collagène de type V",
"description": "Comment diagnostiquer une anomalie du collagène de type V ?\nQuels examens sont utilisés pour évaluer le collagène de type V ?\nLes tests sanguins peuvent-ils détecter des problèmes de collagène ?\nQuels symptômes peuvent indiquer un problème de collagène de type V ?\nLe diagnostic précoce est-il important pour le collagène de type V ?",
"url": "https://questionsmedicales.fr/mesh/D024062?mesh_terms=Cataract#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Collagène de type V",
"description": "Quels sont les symptômes d'une déficience en collagène de type V ?\nLa fatigue est-elle un symptôme lié au collagène de type V ?\nDes problèmes respiratoires peuvent-ils être liés au collagène de type V ?\nLes troubles de la vision sont-ils associés au collagène de type V ?\nComment les symptômes varient-ils selon l'âge ?",
"url": "https://questionsmedicales.fr/mesh/D024062?mesh_terms=Cataract#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Collagène de type V",
"description": "Peut-on prévenir les troubles liés au collagène de type V ?\nL'exercice régulier aide-t-il à maintenir la santé du collagène ?\nLes habitudes alimentaires influencent-elles le collagène ?\nLe tabagisme affecte-t-il la santé du collagène ?\nLe stress a-t-il un impact sur le collagène ?",
"url": "https://questionsmedicales.fr/mesh/D024062?mesh_terms=Cataract#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Collagène de type V",
"description": "Quels traitements sont disponibles pour les troubles du collagène de type V ?\nLa thérapie génique est-elle une option pour le collagène de type V ?\nLes suppléments de collagène sont-ils efficaces ?\nLa chirurgie est-elle nécessaire pour traiter les problèmes de collagène ?\nQuels médicaments sont utilisés pour soulager les symptômes ?",
"url": "https://questionsmedicales.fr/mesh/D024062?mesh_terms=Cataract#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Collagène de type V",
"description": "Quelles complications peuvent survenir avec des troubles du collagène de type V ?\nLes troubles du collagène peuvent-ils entraîner des problèmes cardiovasculaires ?\nComment les complications affectent-elles la qualité de vie ?\nLes complications sont-elles réversibles ?\nLes complications peuvent-elles survenir à tout âge ?",
"url": "https://questionsmedicales.fr/mesh/D024062?mesh_terms=Cataract#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Collagène de type V",
"description": "Quels sont les facteurs de risque pour les troubles du collagène de type V ?\nL'âge est-il un facteur de risque pour le collagène de type V ?\nLe sexe influence-t-il le risque de troubles du collagène ?\nLes habitudes de vie affectent-elles le risque de troubles du collagène ?\nLes maladies génétiques sont-elles un facteur de risque ?",
"url": "https://questionsmedicales.fr/mesh/D024062?mesh_terms=Cataract#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une anomalie du collagène de type V ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests génétiques et des biopsies tissulaires."
}
},
{
"@type": "Question",
"name": "Quels examens sont utilisés pour évaluer le collagène de type V ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des analyses histologiques et des tests d'imagerie peuvent être utilisés."
}
},
{
"@type": "Question",
"name": "Les tests sanguins peuvent-ils détecter des problèmes de collagène ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains marqueurs dans le sang peuvent indiquer des anomalies du collagène."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer un problème de collagène de type V ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des douleurs articulaires, des problèmes de peau et des anomalies osseuses peuvent survenir."
}
},
{
"@type": "Question",
"name": "Le diagnostic précoce est-il important pour le collagène de type V ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un diagnostic précoce permet une meilleure gestion des symptômes et des complications."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une déficience en collagène de type V ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des douleurs articulaires, des problèmes de peau et des déformations."
}
},
{
"@type": "Question",
"name": "La fatigue est-elle un symptôme lié au collagène de type V ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la fatigue peut être un symptôme associé à des troubles du collagène."
}
},
{
"@type": "Question",
"name": "Des problèmes respiratoires peuvent-ils être liés au collagène de type V ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anomalies dans le collagène peuvent affecter la fonction pulmonaire."
}
},
{
"@type": "Question",
"name": "Les troubles de la vision sont-ils associés au collagène de type V ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines conditions oculaires peuvent être liées à des anomalies du collagène."
}
},
{
"@type": "Question",
"name": "Comment les symptômes varient-ils selon l'âge ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent s'aggraver avec l'âge, affectant la mobilité et la peau."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les troubles liés au collagène de type V ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée et un mode de vie sain peuvent aider à prévenir certains troubles."
}
},
{
"@type": "Question",
"name": "L'exercice régulier aide-t-il à maintenir la santé du collagène ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier peut renforcer les tissus conjonctifs et améliorer la santé du collagène."
}
},
{
"@type": "Question",
"name": "Les habitudes alimentaires influencent-elles le collagène ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation riche en vitamine C et en acides aminés favorise la production de collagène."
}
},
{
"@type": "Question",
"name": "Le tabagisme affecte-t-il la santé du collagène ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme peut dégrader le collagène et affecter la santé des tissus conjonctifs."
}
},
{
"@type": "Question",
"name": "Le stress a-t-il un impact sur le collagène ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut affecter la production de collagène et la santé des tissus."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les troubles du collagène de type V ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la physiothérapie, les médicaments anti-inflammatoires et la chirurgie."
}
},
{
"@type": "Question",
"name": "La thérapie génique est-elle une option pour le collagène de type V ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "La thérapie génique est en cours d'étude pour traiter certaines anomalies du collagène."
}
},
{
"@type": "Question",
"name": "Les suppléments de collagène sont-ils efficaces ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les suppléments peuvent aider à améliorer la santé des articulations, mais les preuves varient."
}
},
{
"@type": "Question",
"name": "La chirurgie est-elle nécessaire pour traiter les problèmes de collagène ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Dans certains cas, la chirurgie peut être nécessaire pour corriger des déformations."
}
},
{
"@type": "Question",
"name": "Quels médicaments sont utilisés pour soulager les symptômes ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des anti-inflammatoires et des analgésiques sont souvent prescrits pour soulager la douleur."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec des troubles du collagène de type V ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des déformations osseuses, des douleurs chroniques et des problèmes respiratoires."
}
},
{
"@type": "Question",
"name": "Les troubles du collagène peuvent-ils entraîner des problèmes cardiovasculaires ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines anomalies du collagène peuvent augmenter le risque de maladies cardiovasculaires."
}
},
{
"@type": "Question",
"name": "Comment les complications affectent-elles la qualité de vie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent réduire la mobilité et causer des douleurs, affectant la qualité de vie."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être gérées, mais d'autres peuvent être permanentes."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles survenir à tout âge ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications peuvent survenir à tout âge, mais elles sont plus fréquentes chez les personnes âgées."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour les troubles du collagène de type V ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents familiaux, des maladies auto-immunes et des blessures répétées."
}
},
{
"@type": "Question",
"name": "L'âge est-il un facteur de risque pour le collagène de type V ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le vieillissement peut augmenter le risque de troubles liés au collagène."
}
},
{
"@type": "Question",
"name": "Le sexe influence-t-il le risque de troubles du collagène ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines conditions touchent plus fréquemment les femmes que les hommes."
}
},
{
"@type": "Question",
"name": "Les habitudes de vie affectent-elles le risque de troubles du collagène ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des habitudes comme le tabagisme et une mauvaise alimentation augmentent le risque."
}
},
{
"@type": "Question",
"name": "Les maladies génétiques sont-elles un facteur de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines maladies génétiques peuvent prédisposer aux troubles du collagène de type V."
}
}
]
}
]
}
School of Biomedical Engineering, Science and Health Systems, Drexel University, Philadelphia, PA 19104, United States. Electronic address: lh535@drexel.edu.
McKay Orthopaedic Research Laboratory, Department of Orthopaedic Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, United States; Translational Musculoskeletal Research Center, Corporal Michael J. Crescenz Veterans Administration Medical Center, Philadelphia, PA 19104, United States.
College of Food Science and Engineering, Engineering Research Center of Utilization of Tropical Polysaccharide Resources, Ministry of Education, Hainan University, Haikou 570228, China.
94 million people are blind or visually impaired globally, and cataract is the most common cause of blindness worldwide. However, most cases of blindness are avoidable. Cataract is associated with dec...
To explore the utility of the Catquest 9SF visual function (VF) questionnaire along with visual acuity (VA) for determining appropriateness and priority for cataract surgery. To evaluate the feasibili...
Prospective multicentred interventional observational study....
Subjects undergoing sequential cataract surgery in both eyes at 4 sites in Ontario....
We recorded best-corrected VA (BCVA) and VA with current correction (CCVA) in each eye and both eyes (OU) and Catquest-9SF responses on a tablet before and after cataract surgery. Linear regression mo...
Preoperative BCVA and CCVA in the worse eye were significant predictors of change in VF (p = 0.006 and p = 0.008, respectively); subjects with worse VA had a greater improvement in VF after surgery. T...
For patient groups with equal VA, the Catquest-9SF score can help determine priority for surgery. Web-based data capture and interpretation allow for efficient virtual assessments of VF. A BCVA in the...
To describe the clinical and demographic characteristics of patients presenting with cataract at uveitis diagnosis treated at a single institution between 2005 and 2019 and to analyze postoperative ou...
We retrospectively reviewed the medical records of children (<18 years of age) diagnosed with cataract at their initial uveitis presentation who subsequently underwent cataract extraction. Outcome mea...
A total of 14 children (17 eyes) were included. Mean patient age was 7.2 ± 3.9 years. Methotrexate was initiated preoperatively in 11 patients; adalimumab, in 3. Primary intraocular lens was implanted...
In our study cohort, surgery for preexisting cataract at uveitis diagnosis resulted in improved visual acuity. Postoperative uveitis flare-ups were relatively uncommon, occurring in 4 of 17 eyes. Glau...
Cataract is the leading cause of blindness in the world and, as such, cataract surgery is one of the most commonly performed operations globally. Surgical techniques have changed dramatically over the...
To compare the effectiveness and safety of FLACS with standard ultrasound phacoemulsification cataract surgery (PCS) by gathering evidence from randomised controlled trials (RCTs)....
We searched the Cochrane Central Register of Controlled Trials (CENTRAL; which contains the Cochrane Eyes and Vision Trials Register; 2022, Issue 5); Ovid MEDLINE; Ovid Embase; LILACS; the ISRCTN regi...
We included RCTs where FLACS was compared to PCS....
Three review authors independently screened the search results, assessed risk of bias and extracted data using the standard methodological procedures expected by Cochrane. The primary outcome for this...
We included 42 RCTs conducted in Europe, North America, South America and Asia, which enrolled a total of 7298 eyes of 5831 adult participants. Overall, the studies were at unclear or high risk of bia...
To investigate the surgical and pharmacological management and outcomes of patients with cataract and concurrent uveitis....
Data from the Swedish National Cataract Register, 2018-2019, were collected and analysed. Uveitic eyes were identified and eyes without uveitis were used as controls. Generalized estimating equations ...
The study included 719 eyes with and 256 360 without uveitis. The mean age was 66.0 ± 13.5 (standard deviation [SD]) years in the uveitis group and 74.3 ± 8.7 years in the control group (p < 0.001). S...
In this large registry-based Swedish cohort study, the findings demonstrate that cataract surgery in patients with uveitis poses more challenges and requires special surgical precautions. Eyes with co...
This is a 5 years multicentre database study that recruited subjects from the Malaysian Ministry of Health Cataract Surgery Registry (MOH CSR), aimed to determine risk factors that affect cataract sur...
The aim of the study was to evaluate the refractive outcomes of combined cataract surgery and vitrectomy compared to cataract surgery alone....
This retrospective chart review study included two groups: (1) combined surgery in 103 eyes (101 patients) who underwent cataract surgery with posterior chamber intraocular lens (PCIOL) placement by a...
There was no statistically significant difference between predicted and actual postoperative refractive outcomes between the combined and cataract surgery alone groups (within ±0.5 diopters [D], p = 0...
Combined cataract surgery and vitrectomy allows excellent refractive outcomes equal to cataract surgery alone, allowing each procedure to be performed independently by separate anterior and posterior ...
In 2020, almost 100 million people were blind or visually impaired from cataract. Cataract surgery is a cost-effective treatment for cataracts. In Nigeria, twice as many women are cataract blind as me...
A retrospective review of cataract surgery undertaken in all eye health facilities in Imo State in 2019. Data collected included the type and location of facilities, patient demographics and the numbe...
The CSR overall was 330/million and was slightly higher in women (347/million) than in men (315/million) (p<0.001). More elderly women (≥65 years) accessed cataract surgery through outreach than men a...
The overall CSR in Imo state was approximately one-third of that recommended for sub-Saharan Africa. Although the CSR was higher in women than in men, considerably higher CSRs are needed in women to a...
Visual impairment and interventions to preserve vision may impact dementia risk. Thus, we aimed to explore the associations of cataract and cataract surgery with the risk of dementia....
Prospective data from 300,823 individuals in the UK Biobank were used. We used multivariate Cox proportional hazards regression models to estimate hazard ratios (HRs) and 95% confidence intervals for ...
After a mean follow-up of 8.4 years, 3226 individuals were diagnosed with dementia. The nonsurgical cataract group had increased risk of all-cause dementia (HR, 1.214; 95% CI, 1.012-1.456; p = .037) a...
Cataract patients who did not receive surgical treatment had an increased risk of dementia. However, cataract surgery could reverse the risk of dementia. Our findings on brain structures and pathways ...
A teenage boy who was previously diagnosed to have congenital ichthyosis presented to the eye clinic with complaints of gradually decreasing vision in both eyes since childhood. The best-corrected dis...